Quantcast

Industry news that matters to you.  Learn more

Metabolic Test May Predict Pregnant Women at Risk for Preeclampsia

Women can be vulnerable to sudden, sometimes dangerous spikes in blood pressure during pregnancy, part of a condition called preeclampsia. And now scientists say they’ve developed a high-tech method to predict which women are most prone to preeclampsia in late pregnancy — long before symptoms arise.

The approach relies on so-called “metabolic profiling” to track telltale metabolites found in blood plasma. The researchers say these changes could be key indicators for preeclampsia risk.

Simple Blood Test May Detect Alzheimer’s: TTUHSC Researcher Featured in JAMA

The September issue of Archives of Neurology, one of the JAMA/Archives journals, features research, which finds that a simple blood test could diagnose Alzheimer’s disease.

Blood Test Accurately Predicts Death from Prostate Cancer up to 25 Years in Advance

A blood test at the age of 60 can accurately predict the risk that a man will die from prostate cancer within the next 25 years, according to researchers at Memorial Sloan-Kettering Cancer Center, in New York, and Lund University, in Sweden. The findings, published today online in the British Medical Journal, could have important implications for determining which men should be screened after the age of 60 and which may not benefit substantially from continued prostate cancer screening.

Aushon BioSystems Forms Scientific Advisory Board

Aushon BioSystems, Inc., a leading provider of advanced microarray products and laboratory services for biomarker discovery, development and analysis, announced today the formation of a Scientific Advisory Board consisting of internationally renowned physicians and scientists at the forefront of applying biomarker technology in clinical drug development.

Consortium Develops Algorithm from Blood-Based Alzheimer’s Biomarkers

In a study appearing in the newest issue of the Archives of Neurology, members of the Texas Alzheimer’s Research Consortium reported that they have identified protein biomarkers in the blood that can be used to distinguish between individuals with and without Alzheimer’s disease.